A large natural experiment shows that the herpes zoster vaccine reduces dementia diagnoses by 20% over seven years. The ...
The Company recently confirmed that the preliminary HLA prevalence, safety, and immune response data in FLAMINGO-01 patients is trending as expected in both HLA-A*02 and non-HLA-A*02 arms. The non-HLA ...
Glucotrack, Inc. (NASDAQ: GCTK) is focused on the design, development, and commercialization of novel technologies for people with diabetes. The Company is currently developing a long-term implantable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback